Cargando…

ALCAM (CD166) Expression and Serum Levels in Pancreatic Cancer

BACKGROUND: This study was conducted to evaluate the expression of the activated leukocyte cell adhesion molecule (ALCAM) in pancreatic cancer (PAC) and to determine whether or not the ectodomain shedding of ALCAM (s-ALCAM) could serve as a biomarker in the peripheral blood of PAC patients. MATERIAL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tachezy, Michael, Zander, Hilke, Marx, Andreas H., Stahl, Phillip R., Gebauer, Florian, Izbicki, Jakob R., Bockhorn, Maximilian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3380038/ https://www.ncbi.nlm.nih.gov/pubmed/22745698 http://dx.doi.org/10.1371/journal.pone.0039018

Ejemplares similares

Tenascin-C serum levels and its prognostic power in non-small cell lung cancer
por: Gebauer, Florian, et al.
Publicado: (2016)

CXCR7 expression in esophageal cancer
por: Tachezy, Michael, et al.
Publicado: (2013)

CD166/ALCAM Expression Is Characteristic of Tumorigenicity and Invasive and Migratory Activities of Pancreatic Cancer Cells
por: Fujiwara, Kenji, et al.
Publicado: (2014)

Enhanced down-regulation of ALCAM/CD166 in African-American Breast Cancer
por: Tan, Fang, et al.
Publicado: (2014)

Prognostic significance of ALCAM (CD166/MEMD) expression in cutaneous melanoma patients
por: Donizy, Piotr, et al.
Publicado: (2015)

ALCAM/CD166 Is Involved in the Binding and Uptake of Cancer-Derived Extracellular Vesicles
por: Cardeñes, Beatriz, et al.
Publicado: (2022)

ANGI-03 Functional roles of CD166/activated leukocyte cell adhesion molecule (CD166/ALCAM) for glioblastoma invasion
por: Kijima, Noriyuki, et al.
Publicado: (2020)

Activated leukocyte cell adhesion molecule (ALCAM or CD166) modulates bone phenotype and hematopoiesis
por: Hooker, R.A., et al.
Publicado: (2015)

Circulating levels of cell adhesion molecule L1 as a prognostic marker in gastrointestinal stromal tumor patients
por: Zander, Hilke, et al.
Publicado: (2011)

Carcinoembryonic Antigen-Related Cell Adhesion Molecules (CEACAM) 1, 5 and 6 as Biomarkers in Pancreatic Cancer
por: Gebauer, Florian, et al.
Publicado: (2014)

Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse
por: Kahlert, C, et al.
Publicado: (2009)

ALCAM (CD166) as a gene expression marker for human mesenchymal stromal cell characterisation
por: Brinkhof, Bas, et al.
Publicado: (2020)

Sequential neoadjuvant chemoradiotherapy (CRT) followed by curative surgery vs. primary surgery alone for resectable, non-metastasized pancreatic adenocarcinoma: NEOPA- a randomized multicenter phase III study (NCT01900327, DRKS00003893, ISRCTN82191749)
por: Tachezy, Michael, et al.
Publicado: (2014)

Cell Adhesion Molecule CD166/ALCAM Functions Within the Crypt to Orchestrate Murine Intestinal Stem Cell Homeostasis
por: Smith, Nicholas R., et al.
Publicado: (2017)

The Clinical and Theranostic Values of Activated Leukocyte Cell Adhesion Molecule (ALCAM)/CD166 in Human Solid Cancers
por: Yang, Yiming, et al.
Publicado: (2021)

Failure of a Multi-Centric Clinical Trial Investigating Neoadjuvant Radio-Chemotherapy in Resectable Pancreatic Carcinoma (NEOPA-NCT01900327)—Which Lessons Are Learnt?
por: Tachezy, Michael, et al.
Publicado: (2023)

Omental infarction in the postpartum period: a case report and a review of the literature
por: Tachezy, Michael, et al.
Publicado: (2010)

Expression Levels of Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166) in Primary Breast Carcinoma and Distant Breast Cancer Metastases
por: Ihnen, M., et al.
Publicado: (2010)

A novel human recombinant single-chain antibody targeting CD166/ALCAM inhibits cancer cell invasion in vitro and in vivo tumour growth
por: Wiiger, Merete Thune, et al.
Publicado: (2010)

Relevance of activated leukocyte cell adhesion molecule (ALCAM) in tumor tissue and sera of cervical cancer patients
por: Ihnen, Maike, et al.
Publicado: (2012)

Heterogeneity of amplification of HER2, EGFR, CCND1 and MYC in gastric cancer
por: Stahl, Phillip, et al.
Publicado: (2015)

Loss of p16 and high Ki67 labeling index is associated with poor outcome in esophageal carcinoma
por: Jacobsen, Frank, et al.
Publicado: (2020)

ALCAM-EGFR interaction regulates myelomagenesis
por: Luo, Hongmei, et al.
Publicado: (2021)

The CD6/ALCAM pathway promotes lupus nephritis via T cell–mediated responses
por: Chalmers, Samantha A., et al.
Publicado: (2022)

Prognostic Significance of Activated Leukocyte Cell Adhesion Molecule (ALCAM) in Association with Promoter Methylation of the ALCAM Gene in Breast Cancer
por: Jeong, Young Ju, et al.
Publicado: (2018)

Integrin alpha-V is an important driver in pancreatic adenocarcinoma progression
por: Kemper, Marius, et al.
Publicado: (2021)

NF-kappaB P50/P65 hetero-dimer mediates differential regulation of CD166/ALCAM expression via interaction with micoRNA-9 after serum deprivation, providing evidence for a novel negative auto-regulatory loop
por: Wang, Jiayi, et al.
Publicado: (2011)

ALCAM Makes It All Calm by Inhibiting Apoptosis
por: Chen, Peter, et al.
Publicado: (2022)

p53 overexpression is a prognosticator of poor outcome in esophageal cancer
por: Melling, Nathaniel, et al.
Publicado: (2019)

Serum CD166: A novel biomarker for predicting nasopharyngeal carcinoma response to radiotherapy
por: Lin, Huan, et al.
Publicado: (2017)

ALCAM regulates multiple myeloma chemoresistant side population
por: Wang, Fangfang, et al.
Publicado: (2022)

Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand
Publicado: (1995)

Expression and Role of CD166 in the Chronic Kidney Disease
por: Sun, Yan, et al.
Publicado: (2015)

Expression and serum levels of the neural cell adhesion molecule L1-like protein (CHL1) in gastrointestinal stroma tumors (GIST) and its prognostic power
por: Karstens, Karl-Frederick, et al.
Publicado: (2020)

Different Subcellular Localization of ALCAM Molecules in Neuroblastoma: Association with Relapse
por: Corrias, Maria Valeria, et al.
Publicado: (2010)

Increase of ALCAM and VCAM-1 in the plasma predicts the Alzheimer’s disease
por: Chen, Jian, et al.
Publicado: (2023)

Glomangioma of the lung: a case report and review of the literature
por: Gebauer, Florian, et al.
Publicado: (2014)

Minimally invasive surgery for colorectal cancer remains underutilized in Germany despite its nationwide application over the last decade
por: Ghadban, Tarik, et al.
Publicado: (2018)

166 Assessment of Chronic Spontaneous Urticaria by Serum-Induced TNF & ALPHA; and MMP-9 Release
por: Falkencronec, Sidsel, et al.
Publicado: (2012)

Endoscopic vacuum therapy versus stent treatment of esophageal anastomotic leaks (ESOLEAK): study protocol for a prospective randomized phase 2 trial
por: Tachezy, Michael, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_240aeikdm1ih4svl85opd8ac2p